Cargando…
Molecular decoys: antidotes, therapeutics and immunomodulators
Receptor–ligand interactions are fundamental to the regulation of cell physiology, enabling the communication between cells and their environment via signal transduction. Receptors are also exploited by toxins and infectious agents to mediate pathogenesis. Over the past 20 years, however, this bi-pa...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127390/ https://www.ncbi.nlm.nih.gov/pubmed/18977299 http://dx.doi.org/10.1016/j.copbio.2008.10.001 |
_version_ | 1783516349874569216 |
---|---|
author | Gershoni, Jonathan M |
author_facet | Gershoni, Jonathan M |
author_sort | Gershoni, Jonathan M |
collection | PubMed |
description | Receptor–ligand interactions are fundamental to the regulation of cell physiology, enabling the communication between cells and their environment via signal transduction. Receptors are also exploited by toxins and infectious agents to mediate pathogenesis. Over the past 20 years, however, this bi-partite paradigm for cellular regulation, that is, receptors and their ligands, has been revised to include an unforeseen participant namely, soluble receptors or molecular decoys. Decoys function as nature's modifiers of potent responses such as inflammation, stimulation of cell proliferation and triggering apoptosis. Decoys not only provide the means to fine tune the regulation of these phenomena; they also serve as potential leads for the development of recombinant anti-toxins, anti-viral agents and novel therapeutics for combating cancer and inflammatory disease. |
format | Online Article Text |
id | pubmed-7127390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71273902020-04-08 Molecular decoys: antidotes, therapeutics and immunomodulators Gershoni, Jonathan M Curr Opin Biotechnol Article Receptor–ligand interactions are fundamental to the regulation of cell physiology, enabling the communication between cells and their environment via signal transduction. Receptors are also exploited by toxins and infectious agents to mediate pathogenesis. Over the past 20 years, however, this bi-partite paradigm for cellular regulation, that is, receptors and their ligands, has been revised to include an unforeseen participant namely, soluble receptors or molecular decoys. Decoys function as nature's modifiers of potent responses such as inflammation, stimulation of cell proliferation and triggering apoptosis. Decoys not only provide the means to fine tune the regulation of these phenomena; they also serve as potential leads for the development of recombinant anti-toxins, anti-viral agents and novel therapeutics for combating cancer and inflammatory disease. Elsevier Ltd. 2008-12 2008-11-18 /pmc/articles/PMC7127390/ /pubmed/18977299 http://dx.doi.org/10.1016/j.copbio.2008.10.001 Text en Copyright © 2008 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Gershoni, Jonathan M Molecular decoys: antidotes, therapeutics and immunomodulators |
title | Molecular decoys: antidotes, therapeutics and immunomodulators |
title_full | Molecular decoys: antidotes, therapeutics and immunomodulators |
title_fullStr | Molecular decoys: antidotes, therapeutics and immunomodulators |
title_full_unstemmed | Molecular decoys: antidotes, therapeutics and immunomodulators |
title_short | Molecular decoys: antidotes, therapeutics and immunomodulators |
title_sort | molecular decoys: antidotes, therapeutics and immunomodulators |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127390/ https://www.ncbi.nlm.nih.gov/pubmed/18977299 http://dx.doi.org/10.1016/j.copbio.2008.10.001 |
work_keys_str_mv | AT gershonijonathanm moleculardecoysantidotestherapeuticsandimmunomodulators |